Hypertrophic Cardiomyopathy (HCM) Panel
NGS panel analyzing 60 genes for hypertrophic cardiomyopathy, including key sarcomeric and syndromic genes (e.g., MYH7, MYBPC3, TNNT2, TNNI3).
Accessed through the Roadmap2Rare Sponsored Testing Program•Sponsored by Sanofi•Performed by Revvity Omics, Inc.
Designed to help patients understand the purpose of testing and what to expect.
For patients
What this test and program do
If you or a family member has been diagnosed with or is suspected of having hypertrophic cardiomyopathy (HCM), genetic testing can help your doctor better understand your condition and guide care decisions. The Roadmap2Rare program, sponsored by Sanofi and performed by Revvity Omics, covers the full cost of testing so there is no charge to you. Your healthcare provider can order the test and will work with you to decide what testing is right for your situation.
Who this may help
Could this be right for you or your family?
- To qualify, all of the following must be met:
- This program is for diagnostic testing only — not carrier testing
- A doctor confirms the test is medically necessary and that consent was given
- At least one of these is true:
- A heart-muscle condition (cardiomyopathy) with no known cause
- A heart-rhythm problem (arrhythmia) with no known cause
- A confirmed family history of hypertrophic cardiomyopathy (HCM) with no known cause
- The doctor suspects Fabry disease or Pompe disease
- A family member has a known Fabry or Pompe genetic change (familial variant), confirmed by their report
What to expect
How the process works
- 1
Choose & order
Your clinician decides if this test fits your situation and submits the order.
- 2
Collect & ship
Provide the sample using the kit and instructions; the clinic or lab ships it to Revvity.
- 3
Get results
Results go to your clinician, who explains what they mean and next steps.
Cost & coverage
Understanding potential costs
If you qualify for this program, the sponsor works with the laboratory to help make testing more affordable. Many patients pay little or no out-of-pocket cost. Your exact cost will depend on your insurance coverage and the specific criteria of the program, and the lab can explain what to expect before your sample is processed.
Quality & privacy
How your sample and information are handled
Testing is performed by Revvity Omics, Inc., a CLIA-certified laboratory (CLIA 39D0673919). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Common questions about this program
What is the Roadmap2Rare genetic testing program for hypertrophic cardiomyopathy?
Roadmap2Rare is a sponsored diagnostic testing program that can help identify genetic causes of hypertrophic cardiomyopathy (HCM). The program is sponsored by Sanofi, and testing is performed by Revvity Omics, Inc. Your doctor decides which test is appropriate for you and will walk you through the process and your results.
Is Roadmap2Rare genetic testing for HCM really free, and who pays for it?
Yes, testing through the Roadmap2Rare program is provided at no cost to you. Sanofi sponsors the program and covers the cost of testing, so you will not receive a bill, a copay, or any out-of-pocket charge. The program is designed to remove financial barriers so that more people can access the genetic testing they need for hypertrophic cardiomyopathy.
How do I get tested for hypertrophic cardiomyopathy through Roadmap2Rare?
Testing through Roadmap2Rare must be ordered by your healthcare provider. Talk to your doctor about whether genetic testing for hypertrophic cardiomyopathy is right for you. Your clinician will handle the ordering process and will receive results from Revvity Omics, then discuss them with you.
Will I have access to genetic counseling with Roadmap2Rare HCM testing?
Your healthcare provider is responsible for discussing your results and what they mean for your care. If you have questions about the genetic aspects of hypertrophic cardiomyopathy, ask your doctor whether a referral to a genetic counselor would be helpful. Your clinician can guide you to the support and resources that are right for your situation.
Who qualifies for Roadmap2Rare Hypertrophic Cardiomyopathy genetic testing?
Patients may qualify for Roadmap2Rare if they meet the program's eligibility criteria:
- You have a diagnosed heart condition (cardiomyopathy or unexplained heart rhythm problem).
- OR you have a confirmed family history of hypertrophic cardiomyopathy (HCM) without a known cause.
- Not for carrier testing. Your clinician will confirm if this pathway fits your situation.
Questions to ask your doctor about Hypertrophic Cardiomyopathy (HCM) Panel
- Do you think this test is appropriate for me based on my symptoms and history?
- How could the results of this test change my diagnosis or treatment plan?
- What are the potential limitations of this test that I should understand?
- Should any of my family members also be tested based on my results?
- How will we follow up after the results are available?
Notes
See an issue with this program?